The first half of the year has already seen venture funding in healthcare companies reach new highs, according to the Global Healthcare Report, with AI-centric companies no exception. In the second quarter, healthcare AI startups received $864 million in venture capital across a total of 75 deals, up year-over-year from the $764 million the sector earned in the second quarter of 2018.
The report shows that much of the funding went to startups using AI in biotech and biopharma, including a $200 million deal for Chicago-based Tempus, $76 million to San Francisco’s BlackThorn Therapeutics and $67 million for South San Francisco-based Frontier Medicines. AI-enabled imaging has also attracted plenty of venture funding; PathAI, a Boston-based developer of AI tools and services for pathology, raised $60 million in April.
More articles on AI:
Mayo Clinic AI detects recent atrial fibrillation in routine ECG
Microsoft leverages blockchain for AI initiatives
Google’s AI anticipates 90% of kidney failures up to 48 hours prior to symptoms, study shows
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
